Cetera Investment Advisers’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23M Buy
271,542
+3,050
+1% +$246K 0.02% 680
2026
Q1
$19M Sell
268,492
-2,444
-0.9% -$183K 0.02% 707
2025
Q4
$21.4M Sell
270,936
-1,286
-0.5% -$102K 0.02% 638
2025
Q3
$22.4M Buy
272,222
+46,560
+21% +$3.66M 0.03% 602
2025
Q2
$18.1M Buy
225,662
+5,122
+2% +$395K 0.03% 558
2025
Q1
$17.7M Buy
220,540
+31,207
+16% +$2.6M 0.03% 507
2024
Q4
$15.5M Buy
189,333
+4,149
+2% +$345K 0.03% 511
2024
Q3
$15.3M Sell
185,184
-7,347
-4% -$549K 0.03% 520
2024
Q2
$13.5M Sell
192,531
-33,558
-15% -$2.4M 0.03% 541
2024
Q1
$16.8M Buy
226,089
+144,599
+177% +$10.1M 0.04% 443
2023
Q4
$5.39M Buy
81,490
+1,393
+2% +$87.2K 0.04% 406
2023
Q3
$5.04M Sell
80,097
-17,670
-18% -$1.1M 0.04% 416
2023
Q2
$5.53M Sell
97,767
-13,572
-12% -$753K 0.05% 376
2023
Q1
$6.45M Sell
111,339
-125
-0.1% -$8.44K 0.06% 317
2022
Q4
$8.07M Buy
111,464
+47,543
+74% +$3.41M 0.07% 255
2022
Q3
$3.88M Sell
63,921
-5,787
-8% -$370K 0.08% 268
2022
Q2
$4.38M Buy
69,708
+8,834
+15% +$585K 0.07% 291
2022
Q1
$4.28M Buy
60,874
+3,601
+6% +$243K 0.06% 316
2021
Q4
$3.58M Buy
57,273
+2,762
+5% +$173K 0.05% 379
2021
Q3
$3.37M Buy
54,511
+727
+1% +$43.8K 0.05% 372
2021
Q2
$3.22M Buy
53,784
+2,306
+4% +$146K 0.05% 384
2021
Q1
$3.13M Sell
51,478
-1,157
-2% -$63.8K 0.06% 321
2020
Q4
$2.47M Buy
52,635
+17,016
+48% +$737K 0.05% 378
2020
Q3
$1.32M Sell
35,619
-3,819
-10% -$145K 0.11% 212
2020
Q2
$1.44M Buy
39,438
+4,719
+14% +$164K 0.13% 188
2020
Q1
$1.06M Sell
34,719
-994
-3% -$44.1K 0.13% 182
2019
Q4
$1.82M Buy
35,713
+2,911
+9% +$141K 0.18% 138
2019
Q3
$1.55M Buy
32,802
+4,558
+16% +$217K 0.19% 133
2019
Q2
$1.4M Buy
28,244
+1,106
+4% +$52K 0.18% 132
2019
Q1
$1.16M Buy
27,138
+147
+0.5% +$6.5K 0.16% 151
2018
Q4
$1.11M Sell
26,991
-746
-3% -$32K 0.18% 137
2018
Q3
$1.3M Sell
27,737
-1,077
-4% -$49.2K 0.19% 132
2018
Q2
$1.26M Sell
28,814
-4,221
-13% -$197K 0.22% 118
2018
Q1
$1.52M Buy
33,035
+1,409
+4% +$68.4K 0.29% 94
2017
Q4
$1.6M Buy
31,626
+2,417
+8% +$127K 0.29% 93
2017
Q3
$1.52M Buy
29,209
+4,974
+21% +$242K 0.34% 81
2017
Q2
$1.19M Buy
24,235
+1,714
+8% +$79.5K 0.29% 93
2017
Q1
$1.06M Buy
22,521
+9,597
+74% +$458K 0.29% 97
2016
Q4
$621K Buy
12,924
+55
+0.4% +$2.52K 0.21% 132
2016
Q3
$507K Sell
12,869
-5,773
-31% -$217K 0.22% 130
2016
Q2
$663K Buy
18,642
+2,128
+13% +$83K 0.26% 118
2016
Q1
$645K Buy
16,514
+3,023
+22% +$113K 0.28% 107
2015
Q4
$578K Buy
+13,491
New +$593K 0.27% 116

Other funds holding MET

Cetera Investment Advisers's MET Position: Q2 2026 in Review

Cetera Investment Advisers increased its MetLife (MET) stake by 1.1% in Q2 2026, buying an estimated $246K and bringing the position to 271,542 shares worth $23M. The position accounts for 0.02% of the portfolio, ranked #680.

Cetera Investment Advisers first reported a position in MET in Q4 2015 and has held it in 43 quarters since. 1,448 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Cetera Investment Advisers held 271,542 shares of MetLife worth $23M as of Q2 2026.
  • Cetera Investment Advisers bought 3,050 MetLife shares in Q2 2026, an estimated $246K.
  • MetLife made up 0.02% of Cetera Investment Advisers's portfolio in Q2 2026, its #680 holding.
  • Cetera Investment Advisers first reported a position in MetLife in Q4 2015 and has held it in 43 quarters since.
  • 1,448 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.